Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.48Price to Book
VS
Market
Sector
Industry
History
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information
Ticker
SAGECompany Name
SAGE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSAGE THERAPEUTICS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SAGE - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 368.74M | $ 544.97M | 1.48 |
| 3/31/2025 | $ 409.85M | $ 475.92M | 1.16 |
| 12/31/2024 | $ 465.09M | $ 442.05M | 0.95 |
| 9/30/2024 | $ 551.84M | $ 518.75M | 0.94 |
| 6/30/2024 | $ 628.06M | $ 668.5M | 1.06 |
| 3/31/2024 | $ 705.8M | $ 817.27M | 1.16 |
| 12/31/2023 | $ 799.53M | $ 1.55B | 1.94 |
| 9/30/2023 | $ 816.66M | $ 1.18B | 1.44 |
| 6/30/2023 | $ 984.38M | $ 1B | 1.02 |
| 3/31/2023 | $ 1.13B | $ 2.72B | 2.4 |
Key Performance Insights, Last 5 Years
- SAGE THERAPEUTICS INC's latest trailing twelve months (TTM) P/B stands at 6.18.
- Over the past 5 years, SAGE THERAPEUTICS INC's average P/B has been 1.71.
- The median P/B for SAGE THERAPEUTICS INC during this period was 1.4
- SAGE THERAPEUTICS INC reached its highest P/B over the past 5 years at 6.18.
- The lowest P/B recorded by SAGE THERAPEUTICS INC in the same timeframe 0.94
SAGE THERAPEUTICS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for SAGE THERAPEUTICS INC is calculated as follows: Market Cap [ $ 4.07B ] / Equity [ $ 657.58M ]
(=) P/B [ 6.18 ] SAGE - Price to Book, Last 5 years
0.94
Minimum
Sep 30, 2024
6.18
Maximum
Sep 30, 2020
1.71
Average
1.4
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |